Ascendiant Initiates Research Coverage on SINTX Technologies, Inc.  (NasdaqCM: SINT)
IRVINE, Calif., September 11, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on SINTX Technologies, Inc. (NasdaqCM: SINT) of Salt Lake City, Utah.  For a copy of the initiation report, please click here.

Ascendiant Serves as Sole Placement Agent on $2,635,000 Private Placement for Hemispherx Biopharma, Inc. (NYSE American: HEB)
IRVINE, Calif., August 14, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the closing of a $2,635,000 Private Placement for Hemispherx Biopharma (NYSE American: HEB) of Ocala, Florida.  For a copy of the announcement, please click here.

Ascendiant Serves as Sole Sales Agent on $5,500,000 At-the-Market Offering for DPW Holdings, Inc. (NYSE American: DPW)
IRVINE, Calif., August 6, 2019 -- Ascendiant Capital Markets, LLC announced today the closing of a $5,500,000 At-the-Market Offering for DPW Holdings, Inc. (NYSE American: DPW) of Newport Beach, California.  For a copy of the announcement, please click here.

Ascendiant Initiates Research Coverage on Myomo, Inc.  (NYSE American: MYO)
IRVINE, Calif., July 30, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Myomo, Inc. (NYSE American: MYO) of Cambridge, Massachusetts.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on BioHiTech Global, Inc.  (NasdaqCM: BHTG)
IRVINE, Calif., July 22, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on BioHiTech Global, Inc. (NasdaqCM: BHTG) of Chestnut Ridge, New York.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on Nemaura Medical, Inc.  (NasdaqCM: NMRD)
IRVINE, Calif., June 20, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Nemaura Medical, Inc. (NasdaqCM: NMRD) of Loughborough, Leicestershire, United Kingdom.  For a copy of the initiation report, please click here.

Ascendiant Serves as Financial Advisor on $5,420,000 Public Offering for Summit Wireless Technologies, Inc. (NasdaqCM: WISA)
IRVINE, Calif., May 31, 2019 -- Ascendiant Capital Markets, LLC announced today the closing of a $5,420,000 Public Offering for Summit Wireless Technologies, Inc. (NasdaqCM: WISA) of San Jose, California.  For a copy of the announcement, please click here.

Ascendiant Initiates Research Coverage on Daxor Corporation  (NYSE American: DXR)
IRVINE, Calif., May 15, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Daxor Corporation (NYSE American: DXR) of New York, New York.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on Monaker Group, Inc.  (NasdaqCM: MKGI)
IRVINE, Calif., May 13, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Monaker Group, Inc. (NasdaqCM: MKGI) of Weston, Florida.  For a copy of the initiation report, please click here.

Ascendiant Serves as Financial Advisor on $10,700,000 Registered Direct Offering for Novus Therapeutics, Inc. (NasdaqCM: NVUS)
IRVINE, Calif., May 2, 2019 -- Ascendiant Capital Markets, LLC announced today the closing of a $10,700,000 Registered Direct Offering for Novus Therapeutics, Inc. (NasdaqCM: NVUS) of Irvine, California.  For a copy of the announcement, please click here.

Ascendiant Initiates Research Coverage on Outlook Therapeutics, Inc.  (NasdaqCM: OTLK)
IRVINE, Calif., April 22, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Outlook Therapeutics, Inc. (NasdaqCM: OTLK) of Cranbury, New Jersey.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on ENDRA Life Sciences, Inc.  (NasdaqCM: NDRA)
IRVINE, Calif., April 10, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on ENDRA Life Sciences, Inc. (NasdaqCM: NDRA) of Ann Arbor, Michigan.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on FlexShopper, Inc.  (NasdaqCM: FPAY)
IRVINE, Calif., April 9, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on FlexShopper, Inc. (NasdaqCM: FPAY) of Boca Raton, Florida.  For a copy of the initiation report, please click here.

Ascendiant Serves as Financial Advisor on $12,500,000 Public Offering for Oragenics, Inc. (NYSE American: OGEN)
IRVINE, Calif., April 2, 2019 -- Ascendiant Capital Markets, LLC announced today the closing of a $12,500,000 Public Offering for Oragenics, Inc. (NYSE American: OGEN) of Tampa, Florida.  For a copy of the announcement, please click here.

Ascendiant Serves as Sole Placement Agent on $2,215,000 Private Placement for NovaBay Pharmaceuticals, Inc. (NYSE American: NBY)
IRVINE, Calif., March 28, 2019 -- Ascendiant Capital Markets, LLC announced today the closing of a $2,215,000 Private Placement for NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) of Emeryville, California.  For a copy of the announcement, please click here.

Ascendiant Serves as Co-Manager on $5,300,000 Public Offering for Hemispherx Biopharma, Inc. (NYSE American: HEB)
IRVINE, Calif., March 11, 2019 -- Ascendiant Capital Markets, LLC announced today the closing of a $5,300,000 Public Offering for Hemispherx Biopharma, Inc. (NYSE American: HEB) of Ocala, Florida.  For a copy of the announcement, please click here.

Ascendiant Initiates Research Coverage on Oragenics, Inc.  (NYSE American: OGEN)
IRVINE, Calif., March 11, 2019 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Oragenics, Inc. (NYSE American: OGEN) of Tampa, Florida.  For a copy of the initiation report, please click here.

Ascendiant Serves as Financial Advisor on $2,000,000 Private Placement for Outlook Therapeutics, Inc. (NasdaqCM: OTLK)
IRVINE, Calif., March 8, 2019 -- Ascendiant Capital Markets, LLC announced today the completion of a $2,000,000 Private Placement for Outlook Therapeutics, Inc. (NasdaqCM: OTLK) of Cranbury, New Jersey.  For a copy of the announcement, please click here.

Ascendiant Serves as Financial Advisor on $30,000,000 Private Placement for a subsidiary of Aemetis, Inc. (NasdaqGM: AMTX)
IRVINE, Calif., January 7, 2019 -- Ascendiant Capital Markets, LLC announced today the closing of a $30,000,000 private placement for Aemetis Biogas LLC, a subsidiary of Aemetis, Inc. (NasdaqGM: AMTX) of Cupertino, California.  For a copy of the announcement, please
 click here.

Ascendiant Serves as Co-Manager on $20,000,000 Public Offering for RedHill Biopharma Ltd (NasdaqGM: RDHL)
IRVINE, Calif., December 11, 2018 -- Ascendiant Capital Markets, LLC announced today the closing of a $20,000,000 Public Offering for RedHill Biopharma Ltd. (NasdaqGM: RDHL) of Tel-Aviv, Israel.  For a copy of the announcement, please click here.

Ascendiant Serves as Financial Advisor on $12,500,000 Private Placement for Biolase, Inc. (NasdaqCM: BIOL)
IRVINE, Calif., November 13, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the closing of a $12,500,000 Private Placement for Biolase, Inc. (NasdaqCM: BIOL) of Irvine, California.  For a copy of the announcement, please click here.

Ascendiant Initiates Research Coverage on Hemispherx Biopharma, Inc.  (NYSE American: HEB)

IRVINE, Calif., October 29, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Hemispherx Biopharma, Inc. (NYSE American: HEB) of Ocala, Florida.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on Summit Wireless Technologies, Inc. (NasdaqCM: WISA)
IRVINE, Calif., October 10, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Summit Wireless Technologies, Inc. (NasdaqCM: WISA) of San Jose, California.  For a copy of the initiation report, please click here.

Ascendiant Serves as Placement Agent on $3,200,000 Private Placement for Hemispherx Biopharma, Inc. (NYSE American: HEB)
IRVINE, Calif., September 28, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the closing of a $3,200,000 Private Placement for Hemispherx Biopharma (NYSE American: HEB) of Ocala, Florida.  For a copy of the announcement, please click here.

Ascendiant Serves as Financial Advisor on $25,000,000 Public Offering for RedHill Biopharma (NasdaqGM: RDHL)

IRVINE, Calif., August 14, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the closing of a $25,000,000 Public Offering for RedHill Biopharma Ltd (NasdaqGM: RDHL) of Tel-Aviv, Israel.  For a copy of the announcement, please click here.

Ascendiant Serves as M&A Advisor to Vista Dental Products in Sale to Inverness Graham
IRVINE, Calif., June 29, 2018 -- Ascendiant Capital Markets LLC (“Ascendiant”) announced today the completion of the sale of Vista Dental Products (“Vista”) of Racine, Wisconsin to Inverness Graham of Newtown Square, Pennsylvania.  Ascendiant served as the exclusive M&A advisor to Vista on the transaction.  For a copy of the announcement, please click here.
 

Ascendiant Initiates Research Coverage on ADOMANI, Inc. (NasdaqCM: ADOM)
IRVINE, Calif., June 19, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on ADOMANI, Inc. (NasdaqCM: ADOM) of Corona, California.  For a copy of the initiation report, please click here

Ascendiant Serves as M&A Advisor to Tri State Supply Co. in Sale to Consolidated Electrical Distributors
IRVINE, Calif., April 30, 2018 -- Ascendiant Capital Markets LLC (“Ascendiant”) announced today the completion of the sale of Tri State Supply Co. (“Tri State”) of Washington, Pennsylvania to Consolidated Electrical Distributors (“CED”) of Irving, Texas.  Ascendiant served as the exclusive M&A advisor to Tri State on the transaction.  For a copy of the announcement, please click here.

Ascendiant Initiates Research Coverage on ENSERVCO Corporation (NYSE American: ENSV)

IRVINE, Calif., April 25, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on ENSERVCO Corporation (NYSE American: ENSV) of Denver, Colorado.   For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on IsoRay, Inc. (NYSE American: ISR)
IRVINE, Calif., April 2, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on IsoRay, Inc. (NYSE American: ISR) of Richland, Washington.   For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on Aemetis, Inc. (NasdaqCM: AMTX)
IRVINE, Calif., March 5, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Aemetis, Inc. (NasdaqCM: AMTX) of Cupertino, California.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on ARCA biopharma, Inc. (NasdaqCM: ABIO)
IRVINE, Calif., February 26, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant) announced today the initiation of research coverage on ARCA biopharma, Inc. (NasdaqCM: ABIO) of Westminster, Colorado.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on Novus Therapeutics, Inc. (NasdaqCM: NVUS)
IRVINE, Calif., February 13, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on Novus Therapeutics, Inc. (NasdaqCM: NVUS) of Irvine, California.  For a copy of the initiation report, please click here.

Ascendiant Initiates Research Coverage on LRAD Corporation (NasdaqCM: LRAD)
IRVINE, Calif., January 16, 2018 -- Ascendiant Capital Markets, LLC ("Ascendiant") announced today the initiation of research coverage on LRAD Corporation (NasdaqCM: LRAD) of San Diego, California.  For a copy of the initiation report, please click here.

Ascendiant Completes the Sale of Safe-Flo Dental Products to Crosstex International, Inc.
IRVINE, Calif., December 11, 2017 -- Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the completion of the sale of Safe-Flo Dental Products (“Safe-Flo”) to Crosstex International, Inc., a subsidiary of Cantel Medical Corp. (“Crosstex”).  Ascendiant served as exclusive M&A Advisor to Safe-Flo on the transaction.  For a copy of the announcement, please click here.